Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome

Current Opinion in Pediatrics

Volumn 20, Issue 1, 2008, Pages 103-106

  Chiang, Pei Wen ^a   Aliaga, Sofia ^b   Travers, Sharon ^b   Spector, Elaine ^a   Tsai, Anne Chun Hui ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Androgen insensitivity; Denys Drash syndrome; Nephrotic syndrome; WT1 mutation

Indexed keywords

WT1 PROTEIN;

AMBIGUOUS GENITALIA; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CASE REPORT; DENYS DRASH SYNDROME; GENE MUTATION; GENITAL SYSTEM; HUMAN; INFANT; LABORATORY TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WT1 EXON 6 TRUNCATION;

DENYS-DRASH SYNDROME; EXONS; FEMALE; GENES, WILMS TUMOR; HUMANS; INFANT; MUTATION;

EID: 38149026426     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3282f357eb     Document Type: Article

References (25)

1. Fallat ME, Donahoe PK. Intersex genetic anomalies with malignant potential. Curr Opin Pediatr 2006; 18:305-311.
2. Drash A, Sherman F, Hartmann WH, Blizzard RM. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 1970; 76:585-593.
3. Ahmed SF, Cheng A, Dovey L, et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab 2000; 85:658-665.
4. Deeb A, Mason C, Lee YS, Hughes IA. Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. Clin Endocrinol 2005; 63:56-62.
5. Haqq CM, Donahoe PK. Regulation of sexual dimorphism in mammals. Physiol Rev 1998; 78:1-33.
6. Kuèinskas L, Walter J. Human male sex determination and sexual differentiation: pathways, molecular interactions and genetic disorders. Medicina (Kaunas) 2006; 41:633-640.
7. Wilhelm D, Palmer S, Koopman P. Sex determination and gonadal development in mammals. Physiol Rev 2007; 87:1-28.
8. Haber DA, Buckler AJ, Glaser T, et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 1990; 61:1257-1269.
9. Kreidberg JA, Sariola H, Loring JM, et al. WT-1 is required for early kidney development. Cell 1993; 74:679-691.
10. Moffett P, Bruening W, Nakagama H, et al. Antagonism of WT1 activity by protein self-association. Proc Natl Acad Sci USA 1995; 92:11105-11109.
11. Kohler B, Schumacher V, I'Allemand D, et al. Germline Wilms tumor suppressor gene (WT1) mutation leading to isolated genital malformation without Wilms tumor or nephropathy. J Pediatr 2001; 138:421-424.
12. Melo KF, Martin RM, Costa EM, et al. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J Clin Endocrinol Metab 2002; 87:2500-2505.
13. Kohler B, Pienkowski C, Audran F, et al. An N-terminal WT1 mutation (P181S) in an XY patient with ambiguous genitalia, normal testosterone production, absence of kidney disease and associated heart defect: enlarging the phenotypic spectrum of WT1 defects. Eur J Endocrinol 2004; 150:825-830.
14. Shimamura R, Fraizer GC, Trapman J, et al. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Mullerian-inhibiting substance, and the androgen receptor. Clin Cancer Res 1997; 3:2571-2580.
15. Kohler B, Delezoide AL, Boizet-Bonhoure B, et al. Coexpression of Wilms' tumor suppressor 1 (WT1) and androgen receptor (AR) in the genital tract of human male embryos and regulation of AR promoter activity by WT1. J Mol Endocrinol 2007; 38:547-554.
16. Hohenstein P, Hastie ND. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 2006; 15:R196-R201.
17. Niaudet P, Gubler MC. WT1 and glomerular diseases. Pediatr Nephrol 2006; 21:1653-1660.
18. Scott RH, Stiller CA, Walker L, et al. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 2006; 43:705-715.
19. Little S, Hanks S, King-Underwood L, et al. A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome. Pediatr Nephrol 2005; 20: 81-85.
20. Kist-van Holthe JE, Ho PL, Stablein D, et al. Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2005; 9:305-310.
21. Breslow NE, Grigoriev YA, Peterson SM, et al. End stage renal disease in patients with Wilms tumor: results from the national Wilms tumor study group and the U.S. renal data system. J Urol 2005; 174:1972-1975.
22. Royer-Pokora B, Beier M, Henzler M, et al. Twenty-four new cases of WT1 germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development. Am J Med Genet 2004; 127A:249-257.
23. Ruf RG, Schultheiss M, Lichtenberger A, et al. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int 2004; 66:564-570.
24. Mucha B, Ozaltin F, Hinkes BG, et al. Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 2006; 59:325-331.
25. Aucella F, Bisceglia L, De Bonis P, et al. WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes. Pediatr Nephrol 2006; 21:1393-1398.